Lars Brichta Pharmd

Lars Brichta PharmD PhD is currently serving as the Chief Scientific Officer and Director of Clinical and Scientific Affairs at Chemistry Rx Compounding and Specialty Pharmacy. Previously, Lars Brichta worked as a Biotech Equity Research Associate at Canaccord Genuity Group Inc., and as a Senior Neuroscientist at Rockefeller University. Lars Brichta's research focuses on neurodegenerative diseases, particularly Parkinson's disease. Lars Brichta also has experience as a Researcher at the National Institutes of Health, with a background in G protein-coupled receptors. Lars Brichta holds a PhD in Neurogenetics from the University of Cologne and a Doctor of Pharmacy degree from The Martin Luther University of Halle-Wittenberg.